Liberia
Onchocerciasis status
Onchocerciasis is a country-wide public health problem in Liberia.
People affected by onchocerciasis
- Number of communities in meso/hyper endemic (red) areas (2006): 3546
- Total population in meso/hyper endemic (red) areas (2006): 2 194 117
Projects
- Number of current community-directed treatment with ivermectin (CDTI) projects (2007): 3
- Date first community-directed treatment with ivermectin (CDTI) project was launched: 2000
- Number of national onchocerciasis task force (NOTF)-secretariat supported projects (2007): 0
- Number of vector elimination projects: 0
NOTF-secretariat supported project is based at national level and is responsible for overseeing the implementation of all CDTI projects in the country and ensuring the availability of ivermectin.
- More about CDTI projects
- More about NOTF-secretariat supported projects
- More about vector elimination projects
Ivermectin coverage
Geographical coverage (2007)
- Number of communities treated with ivermectin: 4 370
- Treatment target (number of communities): 5 940
- Geographic coverage: 73.6%
Therapeutic coverage (2007)
- Number of people treated with ivermectin: 2 442 161
- Treatment target (number of people): 3 672 308
- Therapeutic coverage: 66.5%
Training
- Number of trained or retrained community-directed distributors, CDDs (2007): 16 987
- Number of people per community-directed distributor, CDD (2007): 216
- Number of trained or retrained health workers (2007): 317
Funds
Projects are funded from three primary sources:
- the APOC Trust Fund
- the government of the country where the projects are being implemented
- funds from non-governmental development organization partners.
Partners
International non-governmental development organization (NGDO) partners (2007):
- Sight Savers International
- Christian Health Association of Liberia